StockNews.AI
TWST
StockNews.AI
15 days

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

1. Twist Bioscience announced strong financial results for Q3 fiscal 2025. 2. The company's robust balance sheet supports its business strategy.

Earnings
-15.68%Current Return
VS
+1.16%S&P 500
$33.6808/04 07:28 AM EDTEvent Start
$28.399108/05 02:21 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Strong financial performance typically boosts investor confidence. Historically, such announcements correlate with positive stock movement.

How important is it?

Positive earnings reports significantly affect stock valuations, indicating strong operational management.

Why Short Term?

Immediate investor reactions to quarterly results affect stock prices swiftly. Previous earnings reports show significant impacts within weeks.

Related Companies

AMGNILMNSGEN
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025. “A strong balance sheet and disciplined cost-management underpin our focused business execution,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. Visit the Events and Presentations page of the Investor Relations section under the “Company” ta.

Related News